We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APEN
526
DELISTED
Apollo Endosurgery, Inc.
APEN
| $929K | ﹤0.01% |
+168,533
| New | +$935K |
|
|
VGR
527
DELISTED
Vector Group Ltd.
VGR
| $917K | ﹤0.01% |
+104,087
| New | +$1.06M |
|
|
IEA
528
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $915K | ﹤0.01% |
67,578
-39,208
| -37% | -$509K |
|
529
Capital City Bank Group
CCBG
$890M
| $907K | ﹤0.01% |
29,164
+321
| +1% | +$10.2K |
|
530
Northeast Bank
NBN
$1.14B
| $901K | ﹤0.01% |
24,576
+270
| +1% | +$10.6K |
|
531
Capital Bancorp
CBNK
$591M
| $872K | ﹤0.01% |
37,762
+415
| +1% | +$9.92K |
|
532
Hancock Whitney
HWC
$6.07B
| $869K | ﹤0.01% |
+15,548
| New | +$748K |
|
533
InMode
INMD
$884M
| $862K | ﹤0.01% |
29,614
+590
| +2% | +$18.3K |
|
|
GTY
534
Getty Realty Corp
GTY
$2.12B
| $851K | ﹤0.01% |
31,643
-981
| -3% | -$28.2K |
|
|
MCHB
535
Mechanics Bancorp
MCHB
$3.46B
| $826K | ﹤0.01% |
28,660
-523
| -2% | -$18.4K |
|
536
Dropbox
DBX
$7.13B
| $824K | ﹤0.01% |
39,752
+785
| +2% | +$17.6K |
|
537
Tiptree Inc
TIPT
$678M
| $823K | ﹤0.01% |
76,475
+841
| +1% | +$9.59K |
|
538
Warrior Met Coal
HCC
$4.26B
| $792K | ﹤0.01% |
27,840
-379
| -1% | -$11.7K |
|
539
AerCap
AER
$23.9B
| $774K | ﹤0.01% |
18,287
+117
| +0.6% | +$5.17K |
|
540
Byline Bancorp
BY
$1.76B
| $773K | ﹤0.01% |
38,192
+420
| +1% | +$9.62K |
|
541
Euroseas
ESEA
$537M
| $770K | ﹤0.01% |
45,489
+9,662
| +27% | +$182K |
|
|
HONE
542
DELISTED
HarborOne Bancorp
HONE
| $767K | ﹤0.01% |
57,168
+628
| +1% | +$8.85K |
|
|
ESTE
543
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $765K | ﹤0.01% |
62,128
+39,641
| +176% | +$539K |
|
544
Jazz Pharmaceuticals
JAZZ
$16B
| $752K | ﹤0.01% |
5,643
+114
| +2% | +$17.3K |
|
545
Ooma
OOMA
$571M
| $752K | ﹤0.01% |
61,103
+19,900
| +48% | +$247K |
|
|
ALE
546
DELISTED
Allete
ALE
| $747K | ﹤0.01% |
14,918
-519
| -3% | -$30.9K |
|
547
Acuity Brands
AYI
$10.1B
| $741K | ﹤0.01% |
4,708
+93
| +2% | +$15.7K |
|
|
EXE
548
Expand Energy Corp
EXE
$21.7B
| $734K | ﹤0.01% |
7,795
-212
| -3% | -$19.9K |
|
549
Forward Air
FWRD
$466M
| $731K | ﹤0.01% |
8,095
+162
| +2% | +$15.9K |
|
550
Richardson Electronics
RELL
$269M
| $725K | ﹤0.01% |
+48,004
| New | +$758K |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.